The race is on to develop the first daily weight-loss pill that would be both cheaper and less invasive than the current ...

Four key factors can greatly impact how much weight people lose while taking GLP-1 drugs like Ozempic, Wegovy, Victoza, and ...

According to the Ozempic prescribing information, you should stop taking Ozempic at least two months before a planned ...

However, when Ozempic, an anti-diabetic medication used to treat Type 2 diabetes, was found to have weight loss as a ...

Extreme hunger is common after people stop taking GLP-1 drugs like Ozempic and Wegovy, but health experts say these simple ...

As interest grows to see what else Ozempic-like drugs can treat, such as substance abuse, experts said "continued vigilance ...

Discover what the supplement Lemme GLP-1 Daily does and whether its ingredients are really effective for weight and blood ...

Researchers found that patients with obesity had an average weight loss of 12.9% with semaglutide vs 5.6% with liraglutide ...

While Novo is struggling to keep up with demand for its obesity drugs, U.S. rival Eli Lilly sees supply restraints easing.

Novo Nordisk presented data on its next-generation weight-loss candidate, amycretin, which showed a significant 13% weight ...

Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion for an update of Novo Nordisk A/S’ (NYSE ...

Novo Nordisk A/S's shares have stalled recently, but this looks like a natural digestion of gains from prior years. Click for ...